Abraham Ceesay

Insider Reports History

Entity
Individual
Location
C/O Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, Burlington, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abraham Ceesay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 626K $6.25M $9.98 Jun 6, 2024 Direct
Cerevel Therapeutics Holdings, Inc. President Restricted Stock Units 29.1K $1.23M $42.24 Feb 6, 2023 Direct
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 81.7K $816K $9.98 Jun 6, 2024 By Ceesay Family Irrevocable Trust
Rapport Therapeutics, Inc. Chief Executive Officer, Director Common Stock 81.7K $816K $9.98 Jun 6, 2024 By Dorothy Ceesay Irrevocable Trust
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 12.2K $324K $26.59 Jun 12, 2024 Direct
Pacira BioSciences, Inc. Director Common Stock 5.23K $148K $28.38 Jun 12, 2024 Direct
Rapport Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 428K Feb 3, 2025 Direct
Cerevel Therapeutics Holdings, Inc. President Stock Option (Right to Buy) 114K Feb 6, 2023 Direct
Cerevel Therapeutics Holdings, Inc. President Common Stock 0 $42.24 Sep 8, 2022 Direct

Insider Reports Filed by Abraham Ceesay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Feb 3, 2025 1 $0 4 Feb 4, 2025 Chief Executive Officer, Director
PCRX Pacira BioSciences, Inc. Jun 12, 2024 2 $0 4 Jun 13, 2024 Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Chief Executive Officer, Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Chief Executive Officer, Director
PCRX Pacira BioSciences, Inc. Oct 6, 2023 1 $0 4 Oct 11, 2023 Director
PCRX Pacira BioSciences, Inc. Oct 6, 2023 0 $0 3 Oct 11, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 President
CERE Cerevel Therapeutics Holdings, Inc. Sep 8, 2022 3 -$371K 4 Sep 12, 2022 President
CERE Cerevel Therapeutics Holdings, Inc. Aug 22, 2022 3 -$186K 4 Aug 24, 2022 President
CERE Cerevel Therapeutics Holdings, Inc. Aug 15, 2022 3 -$201K 4 Aug 17, 2022 President
CERE Cerevel Therapeutics Holdings, Inc. Aug 5, 2022 7 -$1.23M 4 Aug 9, 2022 President
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 President
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 President
CERE Cerevel Therapeutics Holdings, Inc. May 3, 2021 0 $0 3 May 13, 2021 President